The overlooked 'nonclassical' functions of major histocompatibility complex (MHC) class II antigens in immune and nonimmune cells

Journal of Cellular Physiology

Volumn 179, Issue 3, 1999, Pages 251-256

  Altomonte, Maresa ^a   Pucillo, Carlo ^b   Maio, Michele ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN;

ARTICLE; AUTOIMMUNE DISEASE; HUMAN; IMMUNOCOMPETENT CELL; INFECTION; INFLAMMATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SOLID TUMOR;

B-LYMPHOCYTES; BONE MARROW CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNE SYSTEM; MONOCYTES; T-LYMPHOCYTES;

EID: 0032963728     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199906)179:3<251::AID-JCP2>3.0.CO;2-P     Document Type: Article

References (51)

1. Ahsmann EJM, Boom SE, Lokhorst HM, Rijksen G, Bloem AC. 1997. Anti-adhesive signals are mediated via major histocompatibility complex class II molecules in normal and neoplastic human B cells: correlation with B cell differentiation stage. Eur J Immunol 27: 2688-2695.
2. Altomonte M, Pucillo C, Damante G, Maio M. 1993. Cross-linking of HLA class II antigens modulates the release of tumor necrosis factor-α by the EBV-B lymphoblastoid cell line JY. J Immunol 151:5115-5122.
3. Altomonte M, Simonelli C, Tirelli U, Maio M. 1995. Signaling by HLA class II antigens on B cells. Immunol Today 16:548.
4. Altomonte M, Montagner R, Pucillo C, Maio M. 1996. Triggering of target of antiproliferative antibody-1 (TAPA-1/CD81) up-regulates the release of tumor necrosis factor-α by the EBV-B lymphoblastoid cell line JY. Scand J Immunol 43:367-373.
5. Anderson G, Jenkinson EJ, Moore NC, Owen JJT. 1993. MHC class II positive epithelium and mesenchyme cells are both required for T-cell development in the thymus. Nature 362:70-73.
6. André P, Cambier JC, Wade TK, Raetz T, Wade WF. 1994. Distinct structural compartmentalization of the signal transducing functions of major histocompatibility complex class II (Ia) molecules. J Exp Med 179:763-768.
7. Angelisova P, Hilgert I, Horejsi V. 1994. Association of four antigens of the tetraspan family (CD37, CD53, TAPA-1, and R2/C33) with MHC class II glycoproteins. Immunogenetics 39:249-256.
8. Berrih S, Arenzana-Seisdedos F, Cohen S, Devos R, Charron D, Virelizier JL. 1985. Interferon-gamma modulates HLA class II antigen expression on cultured human thymic epithelial cells. J Immunol 135:1165-1171.
9. Bonnefoy JY, Guillot O, Spits H, Blanchard D, Ishizaka K, Banchereau J. 1988. The low affinity receptor for IgE (CD23) on B lymphocytes is spatially associated with MHC class II antigens. J Exp Med 167:57-72.
10. Cabrera T, Ruiz-Cabello F, Garrido F. 1995. Biological implication of MHC class II expression in tumors. Scand J Immunol 41:398-406.
11. Chia CP, Khrebtukova I, McCluskey J, Wade WF. 1994. MHC class II molecules that lack cytoplasmic domains are associated with the cytoskeleton. J Immunol 153:3398-3407.
12. Coral S, Pucillo C, Leonardi A, Fonsatti E, Altomonte M, Maio M. 1997. Triggering of MHC class II antigens differentially modulates tumor necrosis factor α release by B cells at distinct stage of maturation. Cell Growth Differ 8:581-588.
13. Denning SM, Tuck DT, Singer KH, Haynes BF. 1987. Human thymic epithelial cells function as accessory cells for autologous mature thymocyte activation. J Immunol 138:680-686.
14. Ezepchuk YV, Leung DYM, Middleton MH, Bina P, Reiser R, Norris DA. 1996. Staphyloccocal toxins and protein A differentially induce cytotoxicity and release of tumor necrosis factor-α from human keratinocytes. J Invest Dermatol 107:603-609.
15. Garban F, Truman J-P, Lord J, Drénou B, Plumas J, Jacob MC, Sotto J-J, Charron D, Mooney N. 1998. Signal transduction via human leucocyte antigen class II molecules distinguishes between cord blood, normal, and malignant adult B lymphocytes. Exp Hematol 26:874-884.
16. Garrido F, Cabrera T, Concha A, Glew S, Ruiz-Cabello F, Stern PL. 1993. Natural history of HLA expression during tumor development. Immunol Today 14:491-499.
17. Germain RN, Castellino F, Han R, Reis Sousa C, Romagnoli P, Sadegh-Nasseri S, Zhong G-M. 1996. Processing and presentation of endocytically aquired protein antigens by MHC class II and class I molecules. Immunol Rev 151:5-30.
18. + HLA class II-restricted T cell clones against a human sarcoma: evidence for several recognized antigens. J Immunol 156:2205-2213.
19. + T cells. J Exp Med 173:759-762.
20. Lee JW, Gersuk GM, Kiener PA, Beckham C, Ledbetter A, Deeg HJ. 1997. HLA-triggered inhibition of hemopoiesis involves Fas/Fas ligand interactions and is prevented by c-kit ligand. J Immunol 159:3211-3219.
21. Leonardi A, Altomonte M, Maio M, Tell G, Bearz A, Formisano S, Pucillo C. 1997. Biphasic control of NF-kB activation induced by triggering of MHC class II antigens expressed on B cells. Cytokine 9:295-299.
22. Levy S, Todd SC, Maecker HT. 1998. CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu Rev Immunol 16:89-109.
23. Mehindate K, Al-Daccak R, Schall TJ, Mourad W. 1994. Induction of chemokine gene expression by major histocompatibility complex class II ligands in human fibroblast-like synoviocytes. J Biol Chem 51:32063-32069.
24. Mezzetti M, Soloperto M, Fasoli A, Mattoli S. 1991. Human bronchial epithelial cells modulate CD3 and mitogen-induced DNA synthesis in T cells but function poorly as antigen-presenting cells compared to pulmonary macrophages. J Allergy Clin Immunol 87:930-938.
25. Mourad W, Al-Daccak R, Chatila T, Geha RS. 1993. Staphylococcal superantigens as inducers of signal transduction in MHC class II-positive cells. Semin Immunol 5:47-55.
26. Nabavi N, Freeman GJ, Gault A, Godfrey D, Nadler LM, Glimcher LH. 1992. Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature 360:266-268.
27. Naitoh K, Ichigi Y, Miyake K, Muraguchi A, Kimoto M. 1994. Signal transmission through MHC class II molecules in a human B lymphoid progenitor cell line: different signaling pathways depending on the maturation stages of B cells. Microbiol Immunol 38:967-976.
28. Neurath MF, Stuber ER, Strober W. 1995. BSAP: a key regulator of B-cell development and differentiation. Immunol Today 16:564-569.
29. Odum N, Ledbetter JA, Martin P, Geraghty D, Tsu T, Hansen JA, Gladstone P. 1991. Homotypic aggregation of human cell lines by HLA class II-, class Ia- and HLA-G-specific monoclonal antibodies. Eur J Imunol 21:2121-2131.
30. + CTL clones resist Fas Ligand-induced apoptosis and use Fas/Fas ligand-independent mechanism for tumor killing. J Immunol 161: 1220-1230.
31. Roucard C, Garban F, Mooney NA, Charron DJ, Ericson ML. 1996. Conformation of human leucocyte antigen class II molecules. J Biol Chem 271:13993-14000.
32. Rubinstein E, Le Naour F, Lagaudriere-Gesbert C, Billard M, Conjeaud H, Boucheix C. 1996. CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to MHC class II and VLA integrins. Eur J Immunol 26:2657-2665.
33. Schick MR, Levy S. 1993. The TAPA-1 molecule is associated on the surface of B cells with HLA-DR molecules. J Immunol 151: 4090-4097.
34. Scholl PR, Geha RS. 1994. MHC class II signaling in B-cell activation. Immunol Today 15:418-422.
35. Spertini F, Spits H, Geha RS. 1991. Staphylococcal exotoxins deliver activation signals to human T-cell clones via major histocompatibility complex class II molecules. Proc Natl Acad Sci USA 88:7533-7537.
36. Spertini F, Chatila T, Geha RS. 1992. Signals delivered via MHC class II molecules synergize with signals delivered via TCR/CD3 to cause proliferation and cytokine gene expression in T cells. J Immunol 149:65-70.
37. Szollosi J, Horejsi V, Bene L, Angelisova P, Damjanovich S. 1996. Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY. J Immunol 157:2939-2946.
38. Tabibzadeh SS, Gerber MA, Satyaswaroop PG. 1986. Induction of MHC class II antigen expression in human endometrial epithelial cells in vitro by recombinant γ-interferon. Am J Pathol 125:90-96.
39. Thomas WD, Hersey P. 1998. CD4 T cells kill melanoma cells by mechanisms that are independent of Fas (CD95). Int J Cancer 75:384-390.
40. Trede NS, Geha RS, Chatila T. 1991. Transcriptional activation of IL-1β and tumor necrosis factor-α genes by MHC class II ligands. J Immunol 146:2310-2315.
41. Trede NS, Castigli E, Geha RS, Chatila T. 1993. Microbial superantigens induce NF-kB in the human monocytic cell line THP-1. J Immunol 150:5604-5613.
42. Truman J-P, Garban F, Choqueux C, Charron D, Mooney N. 1996a. HLA class II signaling mediates cellular activation and programmed cell death. Exp Hematol 24:1409-1415.
43. Truman J-P, Choqueux C, Charron D, Mooney N. 1996b. HLA class II molecule signal transduction leads to either apoptosis or activation via two different pathways. Cell Immunol 172:149-157.
44. Truman J-P, Choqueux C, Tschopp J, Vedrenne J, Le Deist F, Charron D, Mooney N. 1997. HLA class II-mediated death is induced via Fas/Fas ligand interactions in human splenic B lymphocytes. Blood 89:1996-2007.
45. Wade WF, Davoust J, Salamero J, Andre' P, Watts TH, Cambier JC. 1993. Structural compartmentalization of MHC class II signaling function. Immunol Today 14:539-546.
46. Wakita H, Tokura Y, Furukawa F, Takigawa M. 1995. Staphylococcal enterotoxin B upregulates expression of ICAM-1 molecules on IFN-gamma-treated keratinocytes cell lines. J Invest Dermatol 105: 536-542.
47. Williams K, Ulvestad E, Antel JP. 1994. B7/BB1 antigen expression on adult human microglia studied in vitro and in situ. Eur J Immunol 24:3031-3037.
48. Xuejun Fan B, Crowe SE, Behar S, Gunasena H, Ye G, Haeberle H, Van Houten N, Gourley WK, Ernst PB, Reyes E. 1998. The effect of class II major histocompatibility complex expression on adherence of Helicobacter pylori and induction of apoptosis in gastric epithelial cells: a mechanism for T helper cell type 1-mediated damage. J Exp Med 10:1659-1669.
49. Yamaguchi M, Gersuk G, Nadler S, Deeg HJ. 1996. MHC class II mediated apoptosis and inhibition of hematopoiesis involves upregulation of tumor necrosis factor alpha. Exp Hematol 24: 1100.
50. Yoshino T, Cao L, Nishiuchi R, Matsuo Y, Yamadori I, Kondo E, Teramoto N, Hayashi K, Takahashi K, Kamikawaji N, Akagi T. 1995. Ligation of HLA class II molecules promotes sensitivity to CD95 (Fas antigen, APO-1)-mediated apoptosis. Eur J Immunol 25:2190-2194.
51. Zuniga-Pflucker JC, Jiang D, Lenardo MJ. 1995. Requirement for TNF-α and IL-1α in fetal thymocyte commitment and differentiation. Science 268:1906-1909.